Variable | Non-rebleeding (N = 76, 74.5%) | Rebleeding (N = 26, 25.5%) | OR | 95% CI | P Value |
Age (years)* | 40 (28 - 60) | 50 (35 - 59) |
|
| P = 0.53 |
Gender n (%) Male Female |
68 (79.1) 18 (20.9) |
11 (68.8) 5 (31.2) |
0.85 |
0.18 - 1.96
|
P = 0.35 |
Etiology n (%) Viral Non-viral |
42 (55.3) 34 (44.7) |
16 (61.5) 10(38.5) |
1.30
|
0.52 - 3.22
|
P= 0.74 |
Comorbidity n (%) Yes No |
11 (14.5) 65 (85.5) |
4 (15.4) 22 (84.6) |
1.07 |
0.31 - 3.72 |
P = 1 |
Hypovolemic shock n (%) Present Absent |
23 (30.3) 53 (69.7) |
13 (50) 13 (50) |
2.30 |
0.90 - 5.70 |
P = 0.1 |
Ascites n (%) None/mild Moderate/severe |
43 (56.6) 33 (43.4) |
12 (46.2) 14 (53.8) |
1.5
|
0.6 - 3.7 |
P = 0.5 |
Encephalopathy n (%) Present Absent |
16 (21.1) 60 (78.9) |
10 (38.5) 16 (61.5) |
2.45 |
0.98 - 6.12 |
P = 0.09 |
Active bleeding n (%) | 11 (14.5) | 5 (19.2) | 1.4 | 0.44 - 4.5 | P = 0.6 |
Clot on varix at endoscope n (%) | 33 (43.4) | 23 (88.5) | 10 | 2.76 - 36.14 | P < 0.0001 |
Hb (mean ± SD) | 7.7 ± 2.2 | 8.8 ± 2.2 |
|
| P = 0.07 |
WBC* | 6 (2.8 - 9.3) | 5.6 (4.1 - 5.6) |
| 0.8 - 5.2 | P = 0.7 |
Platelets* | 90 (55.8 - 150.3) | 87.8 (72.8 - 115.3) |
|
| P = 0.8 |
Albumin* | 2.7 (2.3 - 3.1) | 2.7 (2.2 - 3.1) |
|
| P = 0.7 |
Bilirubin* | 1.3 (0.8 - 2.8) | 3.5 (1.1 - 7.2) |
|
| P = 0.02 |
ALT* | 41.3 (24 - 70) | 30.8 (19 - 56.8) |
|
| P = 0.2 |
AST* | 44.8 (31.5 - 78.5) | 54 (28.5 - 87.8) |
|
| P = 0.9 |
Serum creatinine* | 0.8 (0.6 - 1.1) | 0.8 (0.7 - 0.9) |
|
| P = 0.7 |
Serum Na* | 136 (132.3 - 139) | 134 (131.3 - 139.3) |
|
| P = 0.2 |
INR* | 1.3 (1.2 - 1.6) | 1.8 (1.1 - 2.5) |
|
| P = 0.4 |
CPT score | 8 (7 - 9) | 9.5 (7 - 13) |
|
| P < 0.05 |
CPT class A B C |
7 (22.4) 41 (53.9) 18 (23.7) |
4 (15.4) 9 (34.6) 13 (50) |
|
|
P = 0.04
|
MELD score* | 12.5 (9.3 - 17.8) | 17.3 (10 - 23.7) |
|
| P < 0.05 |
Systolic blood pressure* | 90 (80 - 100) | 85 (80 - 100) |
|
| P = 0.2 |